Your browser doesn't support javascript.
loading
G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits.
Kossatz, Elk; Diez-Alarcia, Rebeca; Gaitonde, Supriya A; Ramon-Duaso, Carla; Stepniewski, Tomasz Maciej; Aranda-Garcia, David; Muneta-Arrate, Itziar; Tepaz, Elodie; Saen-Oon, Suwipa; Soliva, Robert; Shahraki, Aida; Moreira, David; Brea, Jose; Loza, Maria Isabel; de la Torre, Rafael; Kolb, Peter; Bouvier, Michel; Meana, J Javier; Robledo, Patricia; Selent, Jana.
Afiliación
  • Kossatz E; Integrative Pharmacology and Systems Neuroscience Research Group, Hospital del Mar Research Institute, Barcelona, Spain.
  • Diez-Alarcia R; Department of Pharmacology, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Bizkaia, Spain.
  • Gaitonde SA; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Madrid, Spain.
  • Ramon-Duaso C; Instituto de Investigación Sanitaria Biobizkaia, Barakaldo, Bizkaia, Spain.
  • Stepniewski TM; Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, H3T 1J4, Canada.
  • Aranda-Garcia D; Cell-type mechanisms in normal and pathological behaviour Research Group, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Muneta-Arrate I; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute, Barcelona, Spain.
  • Tepaz E; InterAx Biotech AG, PARK InnovAARE, 5234, Villigen, Switzerland.
  • Saen-Oon S; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute, Barcelona, Spain.
  • Soliva R; Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain.
  • Shahraki A; Department of Pharmacology, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Bizkaia, Spain.
  • Moreira D; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Madrid, Spain.
  • Brea J; Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, H3T 1J4, Canada.
  • Loza MI; NBD NOSTRUM BIODISCOVERY, Av. de Josep Tarradellas, 8-10, 3-2, 08029, Barcelona, Spain.
  • de la Torre R; NBD NOSTRUM BIODISCOVERY, Av. de Josep Tarradellas, 8-10, 3-2, 08029, Barcelona, Spain.
  • Kolb P; Pharmaceutical Chemistry, University of Marburg, Marbacher Weg 8, Marburg, 35037, Germany.
  • Bouvier M; Innopharma Drug Screening and Pharmacogenomics Platform. BioFarma research group. Center for Research in Molecular Medicine and Chronic Diseases (CiMUS). Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Meana JJ; Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), Trav. Choupana s/n, 15706, Santiago de Compostela, Spain.
  • Robledo P; Pharmaceutical Chemistry, University of Marburg, Marbacher Weg 8, Marburg, 35037, Germany.
  • Selent J; Innopharma Drug Screening and Pharmacogenomics Platform. BioFarma research group. Center for Research in Molecular Medicine and Chronic Diseases (CiMUS). Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain.
Nat Commun ; 15(1): 4307, 2024 May 29.
Article en En | MEDLINE | ID: mdl-38811567
ABSTRACT
G protein-coupled receptors (GPCRs) are sophisticated signaling machines able to simultaneously elicit multiple intracellular signaling pathways upon activation. Complete (in)activation of all pathways can be counterproductive for specific therapeutic applications. This is the case for the serotonin 2 A receptor (5-HT2AR), a prominent target for the treatment of schizophrenia. In this study, we elucidate the complex 5-HT2AR coupling signature in response to different signaling probes, and its physiological consequences by combining computational modeling, in vitro and in vivo experiments with human postmortem brain studies. We show how chemical modification of the endogenous agonist serotonin dramatically impacts the G protein coupling profile of the 5-HT2AR and the associated behavioral responses. Importantly, among these responses, we demonstrate that memory deficits are regulated by Gαq protein activation, whereas psychosis-related behavior is modulated through Gαi1 stimulation. These findings emphasize the complexity of GPCR pharmacology and physiology and open the path to designing improved therapeutics for the treatment of stchizophrenia.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Serotonina / Receptor de Serotonina 5-HT2A / Trastornos de la Memoria Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Serotonina / Receptor de Serotonina 5-HT2A / Trastornos de la Memoria Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2024 Tipo del documento: Article País de afiliación: España